QIAGEN has a truly global investor base comprised of more than 335 identified institutional investors distributed around the world, including more than a half in North America, about one-third in Europe and the remaining shares in the Asia-Pacific/Japan region. Members of the Managing Board and the supervisory Board in total held approximately 2.5 % of QIAGEN's outstanding common shares at the end of 2016.
|BlackRock, Inc., United States||21,500||9.31|
|PRIMECAP Management Company, United States||16,199||7.02|
|MFS Investment Management, United States||12,133||5.26|
|Franklin Templeton Investment Management, United States||10,311||4.47|
|Wellington Management Company, United States||6,960||3.02|
Status: December 2018